Catalyst Calendar - August 13, 2026 (Morning)

 ## Major Catalysts Mentioned **Anthropic IPO and Acquisition Talks** - Date: October 2026 (IPO), August 13, 2026 (talks to buy Decart AI) - Why it matters: Anthropic is targeting a $2 trillion valuation for its October IPO, signaling a major AI market event with potential to reshape AI sector valuations. The acquisition talks for Decart AI at $6 billion ahead of the IPO highlight aggressive expansion and consolidation in AI. - Stocks affected: **$GOOG**, **$GOOGL**, **$SPCX** **FDA Clearance of Sagimet’s Phase 3 Trial for Acne Treatment Denifanstat** - Date: Not explicitly dated (news reported) - Why it matters: FDA clearance for phase 3 trial is a significant regulatory milestone that could drive Sagimet’s valuation and investor interest if the treatment proves effective. - Stocks affected: Data not available (Sagimet Biosciences) **Shein Hong Kong Market Debut** - Date: August 28, 2026 - Why it matters: Shein’s IPO in Hong Kong represents a major event for the fast-fashion e-commerce sector, potentially impacting retail and consumer discretionary stocks. - Stocks affected: Data not available (Shein) **ECB Final Rate Hike Expected Next Month** - Date: September 2026 (Reuters poll) - Why it matters: The European Central Bank is set to deliver its final rate hike in the shortest tightening cycle since 2011, which could influence European bond yields, equity markets, and currency valuations. - Stocks affected: European financials and exporters (specific tickers not mentioned) **Maersk Q2 Profit Beat and Raised Outlook** - Date: Q2 2026 results reported, outlook raised immediately - Why it matters: Maersk’s strong profit beat and raised outlook amid global trade strains suggest resilience in shipping and logistics, potentially benefiting related industrial and transport stocks. - Stocks affected: Data not available (Maersk) ## Earnings on Deck - **$MSGE** - Reports Q4 2026 earnings (date TBD) - Watch for guidance and dividend outlook after price target raised to $103. - **$AVEX** - Q2 2026 earnings call transcript available - Watch for updates on $650M BlackSea deal and revenue doubling. - **$PEPXY** - Q2 2026 earnings call transcript - Key metric: profit growth impact on shares. - **$AUTSF** - Q2 2026 earnings call transcript - Watch for revenue and order trends, including Amazon deal. - **$LUMO** - Q2 and H1 2026 slides and earnings call - Watch occupancy rates and profit surge driven by Varma acquisition. - **$NOMD** - Earnings beat by €0.06, revenue topped estimates - Watch for continued growth momentum. - **$JD** - H1 2026 earnings call transcript - Watch for profit growth despite revenue decline. - **$OROR** - H2 2026 earnings call transcript - Watch for margin trends and operational strength. - **$TELSY** - Q2 2026 earnings call transcript - Watch for margin concerns and analyst commentary. - **$SITM** - Q2 2026 earnings call transcript - Watch for AI packaging growth engine impact on margins. - **$NVDA** - No specific earnings date but noted for AI-related growth and valuation predictions. - **$META** - Commentary on strong core fundamentals with CapEx uncertainties; no earnings date given. ## Economic Events - July Consumer Price Index (CPI) inflation data released recently, showing stickier inflation than expected, influencing Fed rate expectations. - University of Michigan sentiment report scheduled for Friday (date TBD) - important for gauging consumer confidence and potential market impact. - Japan’s wholesale inflation data released, showing sustained high levels supporting expectations of a September BOJ rate hike. - ECB expected to deliver final rate hike next month (September 2026). ## Regulatory & Legal - FDA clearance for Sagimet’s phase 3 trial for acne treatment denifanstat. - Rocket Lab received antitrust clearance for Iridium deal (date TBD). - FTC granted early termination of HSR waiting period for onsemi merger with Synaptics. ## What's NOT Dated But Worth Tracking - Tesla marketing strategy concerns raised by analyst Gary Black, urging a shift to Apple-style marketing to overcome strategic missteps and robotaxi delays. - AI’s growing role as a business leverage tool highlighted by Kevin O’Leary, emphasizing the risk for companies not adopting AI. - Nvidia’s AI-related growth and valuation potential, including partnerships with Japanese industrial giants and predictions of reaching $7.5 trillion valuation. - Microsoft and Apple remain focal points for AI and tech sector strength despite recent volatility. - Bitcoin and cryptocurrency market stability near $64,000 with notable outperformers like Monero and Hyperliquid. - Ongoing geopolitical tensions in the Middle East affecting oil prices and supply concerns. - South Korea’s stock market entering a bull phase fueled by AI rally and chip sector strength. ## Highest Conviction Catalyst - What: Anthropic’s $2 trillion valuation target for October 2026 IPO and acquisition talks for Decart AI ahead of the IPO. - When: October 2026 (IPO), August 13, 2026 (acquisition talks) - Why it matters: Anthropic’s IPO represents a landmark event in the AI sector, potentially reshaping valuations and competitive dynamics across the technology landscape. The acquisition of Decart AI for $6 billion signals aggressive expansion and could set a precedent for AI startup valuations. This event will likely influence investor sentiment broadly in AI-related stocks and tech ETFs. - Trade idea: Monitor **$GOOG**, **$GOOGL**, and AI-focused ETFs for volatility and potential upside as Anthropic’s IPO approaches. Consider exposure to AI infrastructure and software companies benefiting from increased AI adoption. --- This briefing highlights explicitly dated events and significant market-moving developments from the provided headlines, focusing on actionable catalysts and earnings to watch.